Olivier Bodenreider1, Laritza M Rodriguez1. 1. Lister Hill National Center for Biomedical Communications, National Library of Medicine, National Institutes of Health, Bethesda, MD.
Abstract
OBJECTIVES: To evaluate the suitability of the ATC/DDD Index (Anatomical Therapeutic Chemical (ATC) Classification System/Defined Daily Dose) for analyzing prescription lists in the U.S. METHODS: We mapped RxNorm clinical drugs to ATC. We used this mapping to classify a large set of prescription drugs with ATC and compared the prescribed daily dose to the defined daily dose (DDD) in ATC. RESULTS: 64% of the 11,422 clinical drugs could be precisely mapped to ATC. 97% of the 87,001 RxNorm codes from the prescription dataset could be classified with ATC, and 97% of the prescribed daily doses could be assessed. CONCLUSIONS: Although the mapping of RxNorm ingredients to ATC appears to be largely incomplete, the most frequently prescribed drugs in the prescription dataset we analyzed were covered. This study demonstrates the feasibility of using ATC in conjunction with RxNorm for analyzing U.S. prescription datasets for drug classification and assessment of the prescribed daily doses.
OBJECTIVES: To evaluate the suitability of the ATC/DDD Index (Anatomical Therapeutic Chemical (ATC) Classification System/Defined Daily Dose) for analyzing prescription lists in the U.S. METHODS: We mapped RxNorm clinical drugs to ATC. We used this mapping to classify a large set of prescription drugs with ATC and compared the prescribed daily dose to the defined daily dose (DDD) in ATC. RESULTS: 64% of the 11,422 clinical drugs could be precisely mapped to ATC. 97% of the 87,001 RxNorm codes from the prescription dataset could be classified with ATC, and 97% of the prescribed daily doses could be assessed. CONCLUSIONS: Although the mapping of RxNorm ingredients to ATC appears to be largely incomplete, the most frequently prescribed drugs in the prescription dataset we analyzed were covered. This study demonstrates the feasibility of using ATC in conjunction with RxNorm for analyzing U.S. prescription datasets for drug classification and assessment of the prescribed daily doses.
Authors: Silvia Ravera; Sylvia A Hummel; Pieter Stolk; Rob E Heerdink; Lolkje T W de Jong-van den Berg; Johan J de Gier Journal: Eur J Clin Pharmacol Date: 2009-07-21 Impact factor: 2.953
Authors: Yingtong Liu; Junguk Hur; Wallace K B Chan; Zhigang Wang; Jiangan Xie; Duxin Sun; Samuel Handelman; Jonathan Sexton; Hong Yu; Yongqun He Journal: Sci Data Date: 2021-01-13 Impact factor: 6.444
Authors: Lisa Bastarache; Jeffrey S Brown; James J Cimino; David A Dorr; Peter J Embi; Philip R O Payne; Adam B Wilcox; Mark G Weiner Journal: Learn Health Syst Date: 2021-10-14
Authors: Sun Jae Park; Young Jun Park; Jooyoung Chang; Seulggie Choi; Gyeongsil Lee; Joung Sik Son; Kyae Hyung Kim; Yun Hwan Oh; Sang Min Park Journal: Sci Rep Date: 2021-11-04 Impact factor: 4.379